Synopsis
0
KDMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Chloroxacillin
2. Cloxacillin
3. Cloxacillin Sodium
4. Cloxacillin, Sodium
5. Sodium Cloxacillin
6. Sodium, Cloxacillin
7. Syntarpen
8. Tegopen
1. Cloxacillin Sodium
2. 7081-44-9
3. Cloxacillin Sodium Monohydrate
4. Bactopen
5. Sodium Cloxacillin Monohydrate
6. Tegopen
7. Orbenin
8. Cloxacillin Sodium Hydrate
9. Ekvacillin
10. Latocillin
11. Cloxypen
12. Methocillin-s
13. Cloxacillin Sodium Salt Monohydrate
14. Cloxacillin (sodium Monohydrate)
15. Cloxacillin (as Sodium)
16. Brl-1621
17. P-25
18. 65lcb00b4y
19. Chebi:34978
20. Monosodium (2s,5r,6r)-6-(3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate Monohydrate
21. Sodium (2s,5r,6r)-6-(3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Hydrate
22. Sodium;(2s,5r,6r)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
23. Staphobristol-250
24. Orbenin Sodium Hydrate
25. Cloxacap
26. Prostaphlin-a Monohydrate
27. Brl-1621 Sodium Salt Monohydrate
28. Unii-65lcb00b4y
29. Cloxacillin Nataarium-1-wasser
30. Cloxapen (tn)
31. Tegopen (tn)
32. Cloxacillin Sodium [usan:usp:jan]
33. 642-78-4
34. Cloxacillin Sodium (usp)
35. Schembl41012
36. Chembl1200388
37. Cloxacillin Sodium [usan]
38. Dtxsid60110018
39. Cloxacillin Sodium [vandf]
40. Bcp13532
41. Cloxacillin Sodium [usp-rs]
42. Cloxacillin Sodium [who-dd]
43. Cloxacillin Sodium [who-ip]
44. Cloxacillin Sodium Hydrate (jp17)
45. Hy-b0466
46. Mfcd00150735
47. S2564
48. Akos015896310
49. Akos015962898
50. Ac-7623
51. Ccg-269503
52. Cloxacillin Sodium [green Book]
53. Cloxacillin Sodium [orange Book]
54. Cloxacillin Sodium Hydrate [jan]
55. Cloxacillin Sodium [ep Monograph]
56. Cloxacillin Sodium [usp Impurity]
57. 1,3-dichloro-7-bromoisoquinoline
58. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, Monosodium Salt, Monohydrate, (2s-(2alpha,5alpha,6beta))-
59. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-, Sodium Salt, Monohydrate
60. As-60182
61. Cloxacillin Sodium [usp Monograph]
62. D02231
63. Ab01568256_01
64. Cloxacillin Sodium Salt Monohydrate [mi]
65. Q-200886
66. Cloxacillin Sodium Hydrate 100 Microg/ml In Methanol
67. Q27116347
68. Z2574937894
69. Cloxacillin Sodium, Antibiotic For Culture Media Use Only
70. Cloxacillin Sodium, European Pharmacopoeia (ep) Reference Standard
71. Cloxacillin Sodium Salt Monohydrate, Beta-lactamase-resistant Antibiotic
72. Cloxacillin Sodium Salt Monohydrate, Vetranal(tm), Analytical Standard
73. Cloxacillin Sodium, United States Pharmacopeia (usp) Reference Standard
74. Cloxacillin Sodium, Pharmaceutical Secondary Standard; Certified Reference Material
75. (2s,5r,6r)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
76. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, Monosodium Salt, Monohydrate, (2s-(2.alpha.,5.alpha.,6.beta.))-
77. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, Sodium Salt, Hydrate (1:1:1), (2s,5r,6r)-
78. Sodium (2s,5r,6r)-6-[[3-(2-chlorophenyl)-5-methyl1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Hydrate
79. Sodium (2s,5r,6r)-6-[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Hydrate
80. Sodium 2,2-dimethyl-6beta-({[5-methyl-3-(2-chlorophenyl)isoxazol-4-yl]carbonyl}amino)penam-3alpha-carboxylate Hydrate
1. 642-78-4
2. Cloxacillin Sodium Anhydrous
3. Sodium Orbenin
4. Syntarpen Sodium Salt
5. Monosodium Cloxacillin
6. Sodium Syntarpen
7. Austrastaph
8. Staphybiotic
9. Ankerbin
10. Ekvacillin
11. Gelstaph
12. Cloxacillin Sodium Salt
| Molecular Weight | 475.9 g/mol |
|---|---|
| Molecular Formula | C19H19ClN3NaO6S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 475.0580785 g/mol |
| Monoisotopic Mass | 475.0580785 g/mol |
| Topological Polar Surface Area | 142 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 728 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13621
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13548
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13557
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13434
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38038
Submission : 2023-04-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13559
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13529
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13474
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8844
Submission : 1990-11-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13795
Submission : 1998-09-01
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Certificate Number : R1-CEP 2003-207 - Rev 07
Status : Valid
Issue Date : 2019-04-24
Type : Chemical
Substance Number : 661
Certificate Number : CEP 2019-277 - Rev 02
Status : Valid
Issue Date : 2023-11-30
Type : Chemical
Substance Number : 661
Certificate Number : CEP 2008-250 - Rev 06
Status : Valid
Issue Date : 2023-11-30
Type : Chemical
Substance Number : 661
Certificate Number : R1-CEP 1998-025 - Rev 08
Status : Valid
Issue Date : 2021-06-10
Type : Chemical
Substance Number : 661
Cloxacillin Sodium, Powder And Compacted
Certificate Number : R1-CEP 1996-091 - Rev 08
Status : Valid
Issue Date : 2021-02-10
Type : Chemical
Substance Number : 661
Cloxacillin Sodium, Sterile, Crystalline
Certificate Number : R1-CEP 2001-241 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2009-10-16
Type : Chemical
Substance Number : 661
Certificate Number : R0-CEP 1997-131 - Rev 01
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2004-11-17
Type : Chemical
Substance Number : 661
Certificate Number : R0-CEP 2010-350 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2013-07-04
Type : Chemical
Substance Number : 661
Cloxacillin Sodium, Powder, Compacted
Certificate Number : R2-CEP 1995-036 - Rev 05
Status : Valid
Issue Date : 2019-11-18
Type : Chemical
Substance Number : 661
Certificate Number : R1-CEP 2001-233 - Rev 03
Status : Withdrawn by Holder
Issue Date : 2013-11-29
Type : Chemical
Substance Number : 661
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] JDMF
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Registration Number : 227MF10133
Registrant's Address : Bhai Mohan Singh Nagar, Toansa, District SBS Nagar (Nawanshahr), Punjab-144 533, Indi...
Initial Date of Registration : 2015-04-30
Latest Date of Registration : 2015-04-30
[Japanese Pharmacopoeia] Cloxacillin Sodium
Registration Number : 218MF11024
Registrant's Address : 12 BONGEUNSA-RO, 114-GIL, GANGNAM-GU, SEOUL, 135-715 KOREA
Initial Date of Registration : 2006-12-28
Latest Date of Registration : 2006-12-28
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Cloxacillin Sodium IP/BP/USP/EP
Date of Issue : 2022-05-19
Valid Till : 2025-05-27
Written Confirmation Number : WC-0010
Address of the Firm : Bhai Mohan Singh Nagar, Toansa, Dist. SBS Nagar (Nawanshahr), Punjab -144533, In...
Cloxacillin Sodium (Sterile) Ph. Eur.
Date of Issue : 2022-08-02
Valid Till : 2025-07-02
Written Confirmation Number : WC-0121
Address of the Firm : Plot No. 68-70, 73-91, 95, 96, 260, 261, IDA, Pashamylaram (village), Patancheru...
Date of Issue : 2022-08-02
Valid Till : 2025-07-02
Written Confirmation Number : WC-0121
Address of the Firm : Plot No. 68-70, 73-91, 95, 96, 260, 261, IDA, Pashamylaram (village), Patancheru...
Date of Issue : 2022-06-07
Valid Till : 2025-06-25
Written Confirmation Number : WC-0023
Address of the Firm : Survey no. 52,53,58,59,61 to 78,127&128, Pydibhimanvaram Village &Sy.No. 1,2,4t0...
Date of Issue : 2024-04-23
Valid Till : 2027-04-01
Written Confirmation Number : WC-0420
Address of the Firm : Plot no. A-619 & 630, RIICO Industrial Area, Bhiwadi -301019, Dist -Alwar, Rajas...
Cloxacillin Sodium Sterile USP/EP/BP
Date of Issue : 2022-08-12
Valid Till : 2025-07-06
Written Confirmation Number : WC-0378
Address of the Firm : Plot No. 100, 118G, Sec-56, Phase-IV, HSIIDC, Kundli, Sonipat, Haryana, INDIA Ku...
Cloxacillin Sodium Sterile BP/USP
Date of Issue : 2022-12-20
Valid Till : 2025-12-20
Written Confirmation Number : WC-0470
Address of the Firm : Plot No. 41, S. V. Cooperative Industrial Estate, Bachupally Village & Mandal, B...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
NDC Package Code : 52946-0701
Start Marketing Date : 2009-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66558-0211
Start Marketing Date : 2022-07-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
45
PharmaCompass offers a list of Cloxacillin Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cloxacillin Sodium manufacturer or Cloxacillin Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cloxacillin Sodium manufacturer or Cloxacillin Sodium supplier.
PharmaCompass also assists you with knowing the Cloxacillin Sodium API Price utilized in the formulation of products. Cloxacillin Sodium API Price is not always fixed or binding as the Cloxacillin Sodium Price is obtained through a variety of data sources. The Cloxacillin Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cloxacillin, Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cloxacillin, Sodium, including repackagers and relabelers. The FDA regulates Cloxacillin, Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cloxacillin, Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cloxacillin, Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cloxacillin, Sodium supplier is an individual or a company that provides Cloxacillin, Sodium active pharmaceutical ingredient (API) or Cloxacillin, Sodium finished formulations upon request. The Cloxacillin, Sodium suppliers may include Cloxacillin, Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Cloxacillin, Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cloxacillin, Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Cloxacillin, Sodium active pharmaceutical ingredient (API) in detail. Different forms of Cloxacillin, Sodium DMFs exist exist since differing nations have different regulations, such as Cloxacillin, Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cloxacillin, Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Cloxacillin, Sodium USDMF includes data on Cloxacillin, Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cloxacillin, Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cloxacillin, Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cloxacillin, Sodium Drug Master File in Japan (Cloxacillin, Sodium JDMF) empowers Cloxacillin, Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cloxacillin, Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Cloxacillin, Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cloxacillin, Sodium suppliers with JDMF on PharmaCompass.
A Cloxacillin, Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Cloxacillin, Sodium Certificate of Suitability (COS). The purpose of a Cloxacillin, Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cloxacillin, Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cloxacillin, Sodium to their clients by showing that a Cloxacillin, Sodium CEP has been issued for it. The manufacturer submits a Cloxacillin, Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cloxacillin, Sodium CEP holder for the record. Additionally, the data presented in the Cloxacillin, Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cloxacillin, Sodium DMF.
A Cloxacillin, Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cloxacillin, Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cloxacillin, Sodium suppliers with CEP (COS) on PharmaCompass.
A Cloxacillin, Sodium written confirmation (Cloxacillin, Sodium WC) is an official document issued by a regulatory agency to a Cloxacillin, Sodium manufacturer, verifying that the manufacturing facility of a Cloxacillin, Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cloxacillin, Sodium APIs or Cloxacillin, Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Cloxacillin, Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Cloxacillin, Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cloxacillin, Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cloxacillin, Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cloxacillin, Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cloxacillin, Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cloxacillin, Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cloxacillin, Sodium suppliers with NDC on PharmaCompass.
Cloxacillin, Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cloxacillin, Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cloxacillin, Sodium GMP manufacturer or Cloxacillin, Sodium GMP API supplier for your needs.
A Cloxacillin, Sodium CoA (Certificate of Analysis) is a formal document that attests to Cloxacillin, Sodium's compliance with Cloxacillin, Sodium specifications and serves as a tool for batch-level quality control.
Cloxacillin, Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Cloxacillin, Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cloxacillin, Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Cloxacillin, Sodium EP), Cloxacillin, Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cloxacillin, Sodium USP).
